Skip to content
aHUS Alliance Action
  • Home
  • About aHUS Alliance
  • Articles
  • Info Centre
  • Patient Associations
  • Clinicians
  • Contact Us
  • Donate
Search this website
Menu Close
  • Home
  • About aHUS Alliance
  • Articles
  • Info Centre
  • Patient Associations
  • Clinicians
  • Contact Us
  • Donate

Publications

Description.

Home » Publications » Page 3

Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingAnticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

Complement, a target for therapy in inflammatory and degenerative diseases.

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingComplement, a target for therapy in inflammatory and degenerative diseases.

Current treatment of atypical hemolytic uremic syndrome

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingCurrent treatment of atypical hemolytic uremic syndrome

Development of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingDevelopment of RA101348, a Potent Cyclic Peptide Inhibitor of C5 for Complement-Mediated Diseases

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingHow I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome

A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingA new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome.

Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingDesign and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases

Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingTailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.

Prevention and treatment of atypical hemolytic uremic syndrome after kidney transplantation.

  • Post author:ahusalliance
  • Post published:December 19, 2016
  • Post category:
  • Post comments:0 Comments

Continue ReadingPrevention and treatment of atypical hemolytic uremic syndrome after kidney transplantation.
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Go to the next page

Quick Links

  • Home
  • About aHuS Alliance
  • Articles
  • Info Center
  • Patient Associations
  • Clinicians
  • Contact Us
  • Donate

Subscribe to our Newsletter

Get all the latest news from the aHUS world. For more information:

Email is required Email is not valid
Thanks for your subscription.
Failed to subscribe, please contact admin.

aHUS Keep Connected

Connect with us

Facebook-f Twitter Instagram Linkedin Envelope
Copyright 2023 - © aHUS alliance